Cargando…

Serum Bile Acid Profiling and Mixed Model Analysis Reveal Biomarkers Associated with Pruritus Reduction in Maralixibat-Treated Patients with BSEP Deficiency

Progressive familial intrahepatic cholestasis (PFIC) is a debilitating disease manifest by severe cholestasis, intractable pruritus and growth delay that ultimately leads to liver failure or transplantation. Maralixibat (MRX) was recently approved for the treatment of cholestatic pruritus in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xueheng, Zhang, Wujuan, Vig, Pamela, Kostrub, Cory, Setchell, Kenneth D. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609791/ https://www.ncbi.nlm.nih.gov/pubmed/36295854 http://dx.doi.org/10.3390/metabo12100952

Ejemplares similares

The feline bile salt export pump: a structural and functional comparison with canine and human Bsep/BSEP
por: van Beusekom, Cyrina D, et al.
Publicado: (2013)

Maralixibat for the treatment of PFIC: Long‐term, IBAT inhibition in an open‐label, Phase 2 study
por: Loomes, Kathleen M., et al.
Publicado: (2022)

Structure based classification for bile salt export pump (BSEP) inhibitors using comparative structural modeling of human BSEP
por: Jain, Sankalp, et al.
Publicado: (2017)

Predictors of 6-year event-free survival in Alagille syndrome patients treated with maralixibat, an ileal bile acid transporter inhibitor
por: Sokol, Ronald J., et al.
Publicado: (2023)

Maralixibat: First Approval
por: Shirley, Matt
Publicado: (2021)

Correction to: Maralixibat: First Approval
por: Shirley, Matt
Publicado: (2021)

Cell-based BSEP trans-inhibition: A novel, non-invasive test for diagnosis of antibody-induced BSEP deficiency
por: Stindt, Jan, et al.
Publicado: (2023)

Resolution of Pruritus in a Child With Alagille Syndrome Treated With Maralixibat for Seven Years: Durable Response and Discontinuation of Other Medications
por: Garcia, Amy, et al.
Publicado: (2023)

Genetic and Proteomic characterization of Bile Salt Export Pump (BSEP) in Snake Liver
por: Tan, Xinle, et al.
Publicado: (2017)

Mechanistic insights into geniposide regulation of bile salt export pump (BSEP) expression
por: Wu, Guixin, et al.
Publicado: (2018)

Structural basis of bile salt extrusion and small-molecule inhibition in human BSEP
por: Liu, Hongtao, et al.
Publicado: (2023)

The Bile Salt Export Pump: Molecular Structure, Study Models and Small-Molecule Drugs for the Treatment of Inherited BSEP Deficiencies
por: Sohail, Muhammad Imran, et al.
Publicado: (2021)

Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study
por: Bowlus, Christopher L., et al.
Publicado: (2023)

Bsep expression in hilar cholangiocarcinoma of rat model
por: Zhang, Meng-yu, et al.
Publicado: (2021)

Early Identification of Clinically Relevant Drug Interactions With the Human Bile Salt Export Pump (BSEP/ABCB11)
por: Pedersen, Jenny M., et al.
Publicado: (2013)

Emodin Rescues Intrahepatic Cholestasis via Stimulating FXR/BSEP Pathway in Promoting the Canalicular Export of Accumulated Bile
por: Xiong, Xiao-Li, et al.
Publicado: (2019)

Differential effects of metformin‐mediated BSEP repression on pravastatin and bile acid pharmacokinetics in humans: A randomized controlled trial
por: Metry, Melissa, et al.
Publicado: (2022)

Hepatic MDR3 expression impacts lipid homeostasis and susceptibility to inflammatory bile duct obstruction in neonates
por: Carey, Alexandra N., et al.
Publicado: (2017)

Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner
por: Myronovych, Andriy, et al.
Publicado: (2013)

Impact of long‐term administration of maralixibat on children with cholestasis secondary to Alagille syndrome
por: Shneider, Benjamin L., et al.
Publicado: (2022)

Placebo‐Controlled Randomized Trial of an Intestinal Bile Salt Transport Inhibitor for Pruritus in Alagille Syndrome
por: Shneider, Benjamin L., et al.
Publicado: (2018)

Role of polymorphic bile salt export pump (BSEP, ABCB11) transporters in anti-tuberculosis drug-induced liver injury in a Chinese cohort
por: Chen, Ru, et al.
Publicado: (2016)

Bile Acid Synthesis Disorder Masquerading as Intractable Vitamin D-Deficiency Rickets
por: Ahmad, Osman, et al.
Publicado: (2018)

Disarranged Sphingolipid Metabolism From Sphingosine-1-Phosphate Lyase Deficiency Leads to Congenital Nephrotic Syndrome
por: Taylor, Veronica A., et al.
Publicado: (2019)

A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis
por: Mayo, Marlyn J., et al.
Publicado: (2019)

Successful treatment of infantile oxysterol 7α-hydroxylase deficiency with oral chenodeoxycholic acid
por: Tang, Yun-Ping, et al.
Publicado: (2021)

Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury
por: Woodhead, Jeffrey L., et al.
Publicado: (2014)

Histological demonstration of BSEP/ABCB11 inhibition in transient neonatal cholestasis: a case report
por: Baghdasaryan, Anna, et al.
Publicado: (2020)

Absence of Bsep/Abcb11 attenuates MCD diet‐induced hepatic steatosis but aggravates inflammation in mice
por: Fuchs, Claudia D., et al.
Publicado: (2020)

Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher Disease
por: Peng, Yanyan, et al.
Publicado: (2021)

Hepatoprotectant Ursodeoxycholyl Lysophosphatidylethanolamide Increasing Phosphatidylcholine Levels as a Potential Therapy of Acute Liver Injury
por: Chamulitrat, Walee, et al.
Publicado: (2012)

Δ4-3-oxosteroid-5β-reductase deficiency: Responses to oral bile acid therapy and long-term outcomes
por: Zhang, Mei-Hong, et al.
Publicado: (2019)

Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH
por: Al-Dury, Samer, et al.
Publicado: (2018)

Bile Acid Profiling Reveals Distinct Signatures in Undernourished Children with Environmental Enteric Dysfunction
por: Zhao, Xueheng, et al.
Publicado: (2021)

Combination of acid β-glucosidase mutation and Saposin C deficiency in mice reveals Gba1 mutation dependent and tissue-specific disease phenotype
por: Liou, Benjamin, et al.
Publicado: (2019)

Essential Fatty Acid Deficiency Associates with Growth Faltering and Environmental Enteric Dysfunction in Children
por: Narvaez-Rivas, Monica, et al.
Publicado: (2023)

The Covert Surge: Murine Bile Acid Levels Are Associated With Pruritus in Pediatric Autoimmune Sclerosing Cholangitis
por: Meinel, Katharina, et al.
Publicado: (2022)

Pruritus
Publicado: (1876)

Modeling Human Bile Acid Transport and Synthesis in Stem Cell-Derived Hepatocytes with a Patient-Specific Mutation
por: Hayashi, Hisamitsu, et al.
Publicado: (2021)

PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects, GBA1 mutation-associated pathologies and diseases
por: Zhao, Xiangli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_40sgap6gp2l9jemcl5nv4t1k46